Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Pharmacology: Cannabis in neurology--a potted review.

Literature DB >> 25002109

Pharmacology: Cannabis in neurology--a potted review.

Richard Hosking¹, John Zajicek¹.

Abstract

Mesh：

Substances：
Medical Marijuana

Year: 2014 PMID： 25002109 DOI： 10.1038/nrneurol.2014.122

Source DB: PubMed Journal: Nat Rev Neurol ISSN： 1759-4758 Impact factor: 42.937

× No keyword cloud information.

9 in total

1. Loss of striatal type 1 cannabinoid receptors is a key pathogenic factor in Huntington's disease.

Authors: Cristina Blázquez; Anna Chiarlone; Onintza Sagredo; Tania Aguado; M Ruth Pazos; Eva Resel; Javier Palazuelos; Boris Julien; María Salazar; Christine Börner; Cristina Benito; Carolina Carrasco; María Diez-Zaera; Paola Paoletti; Miguel Díaz-Hernández; Carolina Ruiz; Michael Sendtner; José J Lucas; Justo G de Yébenes; Giovanni Marsicano; Krisztina Monory; Beat Lutz; Julián Romero; Jordi Alberch; Silvia Ginés; Jürgen Kraus; Javier Fernández-Ruiz; Ismael Galve-Roperh; Manuel Guzmán
Journal: Brain Date: 2010-10-07 Impact factor: 13.501

2. Effects of cannabis on cognition in patients with MS: a psychometric and MRI study.

Authors: Bennis Pavisian; Bradley J MacIntosh; Greg Szilagyi; Richard W Staines; Paul O'Connor; Anthony Feinstein
Journal: Neurology Date: 2014-04-30 Impact factor: 9.910

3. Endocannabinoid hydrolysis generates brain prostaglandins that promote neuroinflammation.

Authors: Daniel K Nomura; Bradley E Morrison; Jacqueline L Blankman; Jonathan Z Long; Steven G Kinsey; Maria Cecilia G Marcondes; Anna M Ward; Yun Kyung Hahn; Aron H Lichtman; Bruno Conti; Benjamin F Cravatt
Journal: Science Date: 2011-10-20 Impact factor: 47.728

Review 4. Systematic review: efficacy and safety of medical marijuana in selected neurologic disorders: report of the Guideline Development Subcommittee of the American Academy of Neurology.

Authors: Barbara S Koppel; John C M Brust; Terry Fife; Jeff Bronstein; Sarah Youssof; Gary Gronseth; David Gloss
Journal: Neurology Date: 2014-04-29 Impact factor: 9.910

Review 5. Of mice and not men: differences between mouse and human immunology.

Authors: Javier Mestas; Christopher C W Hughes
Journal: J Immunol Date: 2004-03-01 Impact factor: 5.422

Review 6. Therapeutic potential of cannabis in pain medicine.

Authors: R D Hosking; J P Zajicek
Journal: Br J Anaesth Date: 2008-05-29 Impact factor: 9.166

Review 7. Brain regional differences in CB1 receptor adaptation and regulation of transcription.

Authors: M F Lazenka; D E Selley; L J Sim-Selley
Journal: Life Sci Date: 2012-08-24 Impact factor: 5.037

Review 8. Effect of dronabinol on progression in progressive multiple sclerosis (CUPID): a randomised, placebo-controlled trial.

Authors: John Zajicek; Susan Ball; David Wright; Jane Vickery; Andrew Nunn; David Miller; Mayam Gomez Cano; David McManus; Sharukh Mallik; Jeremy Hobart
Journal: Lancet Neurol Date: 2013-07-13 Impact factor: 44.182

9. Association between a genetic variant of type-1 cannabinoid receptor and inflammatory neurodegeneration in multiple sclerosis.

Authors: Silvia Rossi; Marco Bozzali; Monica Bari; Francesco Mori; Valeria Studer; Caterina Motta; Fabio Buttari; Mara Cercignani; Paolo Gravina; Nicolina Mastrangelo; Maura Castelli; Raffaele Mancino; Carlo Nucci; Fabrizio Sottile; Sergio Bernardini; Mauro Maccarrone; Diego Centonze
Journal: PLoS One Date: 2013-12-31 Impact factor: 3.240